Group 1:CAR-T infusion

2 trials

Sponsors

Zhejiang Cancer Hospital, The Third Affiliated Hospital of Guangzhou Medical University

Conditions

Platinum-resistant / refractory Ovarian Cancercolorectal liver metastases

Early Phase 1

Non-viral CAR-T Therapy in Patients with Platinum-Resistant /Refractory Ovarian Cancer

Active, not recruitingChiCTR2000029706

Zhejiang Cancer HospitalPlatinum-resistant / refractory Ovarian Cancer

Start: 2020-02-01Updated: 2020-02-10

Phase 1

Hepatic Artery Transfusion of NKG2D CAR-T Cells to Treat Patients with Previously Treated Liver Metastatic Colorectal Cancer: a Prospective, Multicenter Clinical Trial

RecruitingChiCTR2100053018

The Third Affiliated Hospital of Guangzhou Medical Universitycolorectal liver metastases

Start: 2021-09-01Updated: 2021-11-16